Cancer Genetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CGIX and buy or sell other stocks, ETFs, and their options commission-free!About CGIX
Vyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The firm's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning.
CEOAndrew D. C. LaFrence, CPA
CEOAndrew D. C. LaFrence, CPA
Employees—
Employees—
HeadquartersCherry Hill, New Jersey
HeadquartersCherry Hill, New Jersey
Founded1999
Founded1999
Employees—
Employees—
CGIX Key Statistics
Market cap1.23M
Market cap1.23M
Price-Earnings ratio-0.09
Price-Earnings ratio-0.09
Dividend yield—
Dividend yield—
Average volume45.95K
Average volume45.95K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.58
52 Week high$1.58
52 Week low$0.141
52 Week low$0.141
Stock Snapshot
The current Cancer Genetics(CGIX) stock price is $4.61, with a market capitalization of 1.23M. The stock trades at a price-to-earnings (P/E) ratio of -0.09.
On 2025-12-10, Cancer Genetics(CGIX) stock opened at —, reached a high of —, and a low of —.
The Cancer Genetics(CGIX)'s current trading volume is 0, compared to an average daily volume of 45.95K.
In the last year, Cancer Genetics(CGIX) shares hit a 52-week high of $1.58 and a 52-week low of $0.14.
In the last year, Cancer Genetics(CGIX) shares hit a 52-week high of $1.58 and a 52-week low of $0.14.